Novelix Pharma. (536565)
FAST GROWERScore breakdown: P/E: 0/3 · ROCE: 0/2 · Growth: 2/2 · Dividend: 0/1
Key Financials
| Current Price | ₹19.88 |
| Market Cap | ₹16.1 Cr |
| P/E Ratio | 66.24 |
| ROCE | 0.96% |
| ROE | 20.34% |
| Dividend Yield | 0% |
| Profit Growth | 566.67% |
| Debt/Equity | — |
| Sales Growth | 813.21% |
| 52-Week Range | ₹29.33 — ₹70.16 |
| Sector | Healthcare Services |
| Book Value | ₹4.85 |
Novelix Pharma. trades with a P/E ratio of 66.24, ROCE of 0.96%, ROE of 20.34%, profit growth of 566.67%.
Data from BSE/NSE filings. AI analysis is for educational purposes only — not investment advice. Scoring methodology · Disclaimer